In recent years, as a transcription factor, PBX1 has been abundantly demonstrated to play a key role in tumorigenesis as well as in the pathogenesis of autoimmune diseases (e.g. SLE), and it is increasingly likely to be a therapeutic target. The gene discussed is PBX1; the disease is systemic lupus erythematosus.